Research and education notice: This article is educational and does not provide diagnosis, treatment, dosing, preparation or administration guidance. GenLab Meds products are supplied strictly for controlled laboratory and scientific research and are not intended for human or veterinary use or consumption.
Online communities frequently ask whether weight returns when GLP-1 treatment stops. Clinical extension studies show that regain can occur, but an average trial trajectory cannot predict an individual outcome.
Obesity is a chronic, relapsing condition influenced by biology, environment and behavior. When an effective intervention ends, appetite and energy-balance pressures may re-emerge. This is not evidence of personal failure.
Withdrawal and follow-up studies can compare continued treatment with discontinuation. Interpretation still depends on the population, duration, lifestyle program and missing-data methods.
No. Trial averages conceal wide variation.
Not necessarily. Chronic conditions may require sustained management.
See what research shows about GLP-1 plateaus.
Research and education notice: This article is educational and does not provide diagnosis, treatment, dosing, preparation or administration guidance. GenLab Meds products are supplied strictly for controlled laboratory and scientific research and are not intended for human or veterinary use or consumption.